Skip to main content
. 2020 Feb 18;12(3):467–484. doi: 10.4168/aair.2020.12.3.467

Fig. 3. Trends in the percentage of prescribed medications in (A) uncontrolled asthmatics and (B) the severe asthma group. The proportion of (C) uncontrolled asthmatics and (D) the severe asthma group according to treatment steps.

Fig. 3

SABA, short-acting β2-agonist; SAMA, short-acting muscarinic antagonist; LTRA, leukotriene receptor antagonist; ICS, inhaled corticosteroids; LABA, long-acting β2-agonist; PO, by mouth.